Seattle Children's Hospital

• Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group
• Children with medulloblastoma treated with modified ACNS0821 temozolomide, irinotecan, and bevacizumab: The Seattle Children's Hospital experience
• Stimulant medications affect arousal and reward, not attention
• Identification of GGC Repeat Expansions in ZFHX3 among Chilean Movement Disorder Patients
• Asymptomatic ventriculomegaly in myelomeningocele: a matched cohort study of neuropsychological outcomes across institutions with varying shunt rates
• Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines
• Computational and biological modeling of IGF1R inhibition for multifocal medulloblastoma
• Towards a Definition of Physiologic Vulnerability in Pediatric Spine Surgery: Identification of Key Risk Factors in a Cohort Study of Children With Neuromuscular Disease Undergoing Spinal Fusion

Division of Neurosurgery, Seattle Children's Hospital and Department of Neurological Surgery, University of Washington, Seattle, WA, USA.

https://www.seattlechildrens.org/clinics/neurosciences/services/neurosurgery-program/